Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1α

Diabetes

Volumn 63, Issue 10, 2014, Pages 3266-3278

  Bhalla, Kavita ^a   Liu, Wan Ju ^a   Thompson, Keyata ^a   Anders, Lars ^b   Devarakonda, Srikripa ^b   Dewi, Ruby ^a   Buckley, Stephanie ^a   Hwang, Bor Jang ^a   Polster, Brian ^a   Dorsey, Susan G ^a,c   Sun, Yezhou ^a   Sicinski, Piotr ^b,d   Girnun, Geoffrey D ^a,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; COS 7 CELL LINE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC INHIBITION; METABOLIC REGULATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; ANIMAL; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DIET RESTRICTION; EATING; GENETICS; HEPG2 CELL LINE; HOMEOSTASIS; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; EATING; FASTING; GLUCONEOGENESIS; GLUCOSE; HEP G2 CELLS; HOMEOSTASIS; HUMANS; LIVER; MICE; TRANSCRIPTION FACTORS;

EID: 84907483798     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1283     Document Type: Article

References (47)

1. Liu C, Lin JD. PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2011;43:248-257
2. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006;27:728-735
3. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A coldinducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998;92:829-839
4. Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115-124
5. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001;413:131-138
6. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through F0X01-PGC-1 alpha interaction. Nature 2003;423:550-555
7. Rhee J, Inoue Y, Yoon JC, et al. Regulation of hepatic fasting response by PPARgamma coactivator-1 alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 2003;100:4012-4017
8. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273
9. Mootha VK, Handschin C, Arlow D, et al. Erralpha and Gabpa/b specify PGC-1 alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 2004;101:6570-6575
10. Quinn PG, Yeagley D. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:423-437
11. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006;68:123-158
12. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-1274
13. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011;11:558-572
14. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-5447
15. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997;88:405-415
16. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R. Ligandindependent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev 1998;12:3488-3498
17. Adnane J, Shao Z, Robbins PD. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription. Oncogene 1999;18: 239-247
18. Bienvenu F, Gasean H, Coqueret O. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 2001;276:16840-16847
19. Reutens AT, Fu M, Wang C, et al. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol 2001;15:797-811
20. Wang C, Pattabiraman N, Zhou JN, et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 2003;23:6159-6173
21. Bienvenu F, Jirawatnotai S, Elias JE, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 2010;463:374-378
22. Sakamaki T, Casimiro MC, Ju X, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006;26:5449-5469
23. Wang C, Li Z, Lu Y, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci USA 2006;103:11567-11572
24. Hanse EA, Mashek DG, Becker JR, et al. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Cell Cycle 2012;11:2681-2690
25. Hsiao LL, Dangond F, Yoshida T, et al. A compendium of gene expression in normal human tissues. Physiol Genomics 2001;7:97-104
26. Albrecht JH, Hu MY, Cerra FB. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun 1995;209:648-655
27. Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002;99:4465-4470
28. Hakvoort TB, Moerland PD, Frijters R, et al. Interorgan coordination of the murine adaptive response to fasting. J Biol Chem 2011;286:16332-16343
29. Fry DW, Harvey PJ, Keller PR, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004;3:1427-1438
30. Deane NG, Parker MA, Aramandla R, et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 2001;61 : 5389-5395
31. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-713
32. Baker GL, Landis MW, Hinds PW. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 2005;4:330-338
33. Cooper MP, Qu L, Rohas LM, et al. Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1 alpha/LRP130 complex. Genes Dev 2006;20:2996-3009
34. Gugneja S, Virbasius CM, Scarpulla RC. Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hydrophobic residues to activate transcription. Mol Cell Biol 1996;16:5708-5716
35. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-8471
36. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1 alpha expression in muscle. Proc Natl Acad Sci U S A 2003;100:7111-7116
37. Anders L, Ke N, Hydbring P, et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 2011;20:620-634
38. Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci 2005;30:630-641
39. Ba Y, Zhang CN, Zhang Y, Zhang CY. Down-regulation of PGC-1 alpha expression in human hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 2008; 30:593-597
40. Weinstat-Saslow D, Merino MJ, Manrow RE, et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1995;1:1257-1260
41. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001;411:1017-1021
42. Sicinski P, Donaher JL, Parker SB, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995;82:621-630
43. Estall JL, Kahn M, Cooper MP, et al. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 alpha expression. Diabetes 2009;58:1499-1508
44. Bhalla K, Hwang BJ, Choi JH, et al. N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo. J Biol Chem 2011;286:41626-41635
45. Geng Y, Yu Q, Sicinska E, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-443
46. Bhalla K, Hwang BJ, Dewi RE, et al. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res 2011;71 : 6888-6898
47. Drori S, Girnun GD, Tou L, et al. Hic-5 regulates an epithelial program mediated by PPARgamma [published correction appears in Genes Dev 2005;19: 875], Genes Dev 2005;19:362-375